Recent results of hematopoietic stem cell transplantation for thalassemia with busulfan-based conditioning regimen in France: improved thalassemia free survival despite frequent mixed chimerism. A retrospective study from the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC)

Bone Marrow Transplant. 2023 Nov;58(11):1254-1256. doi: 10.1038/s41409-023-02079-0. Epub 2023 Aug 4.
No abstract available

Publication types

  • Letter

MeSH terms

  • Busulfan / therapeutic use
  • Chimerism
  • France
  • Hematopoietic Stem Cell Transplantation* / methods
  • Humans
  • Retrospective Studies
  • Societies, Medical
  • Stem Cell Transplantation
  • Thalassemia* / therapy
  • Transplantation Conditioning / methods

Substances

  • Busulfan